GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Top Cited Papers
- 24 April 2008
- Vol. 336 (7650), 924-926
- https://doi.org/10.1136/bmj.39489.470347.ad
Abstract
Guidelines are inconsistent in how they rate the quality of evidence and the strength of recommendations. This article explores the advantages of the GRADE system, which is increasingly being adopted by organisations worldwideThis publication has 9 references indexed in Scilit:
- Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working GroupBMC Health Services Research, 2004
- Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular DiseaseAnnals of Internal Medicine, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Guidelines for Counseling Postmenopausal Women about Preventive Hormone TherapyAnnals of Internal Medicine, 1992
- A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction.1992
- A Comparison of Results of Meta-analyses of Randomized Control Trials and Recommendations of Clinical ExpertsJAMA, 1992
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboThe New England Journal of Medicine, 1991
- Aspirin and Reye syndrome. Committee on Infectious Diseases.1982